Last reviewed · How we verify
NCT04139889
Diagnosis of Laryngeal Lesions Using the Probe-based Confocal Laser Endomicroscopy
trial testing Confocal Laser Endomicroscopy in Laryngeal Leiomyoma in 60 participants. Status unknown.
30 November 2019
Quick facts
| Lead sponsor | Eye & ENT Hospital of Fudan University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 1 June 2017 |
| Primary completion | 30 November 2019 |
| Estimated completion | 21 December 2020 |
| Sites | 1 location across China |
Drugs / interventions tested
- Confocal Laser Endomicroscopy
Conditions studied
- Laryngeal Leiomyoma — all drugs for Laryngeal Leiomyoma →
- Probe-based Confocal Laser Endomicroscopy — all drugs for Probe-based Confocal Laser Endomicroscopy →
Sponsor
Eye & ENT Hospital of Fudan University
Who can join
Adults 18 to 85, any sex, with Laryngeal Leiomyoma or Probe-based Confocal Laser Endomicroscopy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the diagnosis of laryngeal lesions using the Probe-based Confocal Laser Endomicroscopy in vivo.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04139889
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Confocal Laser Endomicroscopy
Trials testing the same drug.
- NCT07121920 — Ex-vivo Confocal Imaging and Proteomic Profiling to Determine Treatment Response in Children With IBD · NA · not yet recruiting
- NCT03253458 — Focal Prostate Imaging With CLE and OCT · NA · unknown
Other Eye & ENT Hospital of Fudan University trials
Trials by the same sponsor.
- NCT07522879 — A Study of Becotatug Vedotin (MRG003) Combined With Epirubicin as Neoadjuvant Therapy for EGFR-Positive, Unresectable Re · Phase 2 · not yet recruiting
- NCT07563088 — SPARE-1st: Surgery Alone vs Surgery Plus Postoperative Radiotherapy for Sinonasal Adenoid Cystic Carcinoma · not yet recruiting
- NCT07575334 — Acupuncture Therapy for Sudden Sensorineural Hearing Loss · NA · recruiting
- NCT07320508 — Epirubicin Interventional Chemotherapy for Sinonasal Adenoid Cystic Carcinoma (SNACC): A Prospective Study · Phase 2 · recruiting
- NCT07315802 — New Pattern of Retinal Laser Treatment for PDR · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04139889 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Eye & ENT Hospital of Fudan University
- Last refreshed: 7 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04139889.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing